Much of the wellness and health technology we cover starts in a university or private lab when someone asks themselves a “What if we could…?” question. Some of the survivors of rigorous design and testing cycles then come to life as consumer health products. In the recent past the best of those technologies — meaning those that stand up to inquiry, testing, and peer-reviewed studies — have been adopted or adapted for clinical applications. Neurolign Technology’s NeurolignFit reversed the normal course. Neurolign develops clinical grade eye-tracking technology for neuro-functional diagnostic tracking. According to Neurolign, eye movement tracking can help detect and monitor more than 200 diseases and medical conditions, many associated with brain and neurological health. Early this fall, the company introduced NeurolignFit to help consumers understand and improve their own brain health.
NeurolignFit consists of a handheld device and a mobile app. Consumers can use NeurolignFit’s eye-tracking capability in a series of quick, non-invasive brain health assessments. A Neurolign algorithm uses the assessment data to report on the user’s mental sharpness, focus, and movement. Based on the test results, the app then presents selected gamified exercises to improve their neurological health. The turnabout with NeurolignFit is that the technology used to monitor patient health in clinical settings — typically requiring large, costly devices — has been scaled down for individual use at a consumer-friendly $199 price.
According to Dr. Alex Kiderman, Neurolign VP of Technology Development, “Neurolign’s eye-tracking technology is backed with 30 patents, 60+ research citations, and eight clinical studies in the past year alone, alongside extensive peer consultation.” From our point of view, taking proven technology out of clinical settings in a form and at a price that consumers can use at home not just to perform an assessment, but to provide a way to potentially improve their health is a welcome turnaround.
